Palliative medicine in the elderly

被引:0
作者
Cleary, JF [1 ]
Carbone, PP [1 ]
机构
[1] UNIV WISCONSIN,DEPT MED,PALLIAT MED PROGRAM,MADISON,WI 53792
关键词
palliative medicine; symptom management; pain; fatigue; dyspnea; hospice; death; cancer;
D O I
10.1002/(SICI)1097-0142(19971001)80:7<1335::AID-CNCR21>3.0.CO;2-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer is primarily a disease of the elderly and the palliation of both disease-and treatment-related symptoms is of importance in the practice of cancer medicine in all patients. Many older patients are treated within community hospitals, in which anticancer therapies are less likely to be given and in which the palliation of symptoms should be of primary importance. Many oncologists struggle with the palliation of symptoms in patients who are near the end of life. This is despite the considerable energies that are spent in palliating symptoms in patients who are receiving anticancer therapies at all disease stages. The management of pain has advanced considerably recently with improvements in pain assessment and pharmacologic interventions. However, elderly patients are less likely than younger patients to receive proper pain management. Elderly patients also are less likely to take opioids for pain because of their attitudes and beliefs. Fatigue, dyspnea, and psychologic issues also are of importance in the management of elderly cancer patients both during anticancer therapy and near the time of death. Some elderly cancer patients die in the care of a hospice, although many are not referred to this service. There are many barriers to the provision of palliative medicine and these may be related to health practitioners, to the patients themselves, or to the health care system of which they are part. The increased educational efforts of health professionals are needed to ensure that all patients, including the elderly, have adequate palliation of their cancer-related symptoms. (C) 1997 American Cancer Society.
引用
收藏
页码:1335 / 1347
页数:13
相关论文
共 57 条
[1]  
*AM CANC SOC, 1996, CANC FACTS FIG 1996
[2]  
*AM SOC CLIN ONC, 1996, J CLIN ONCOL, V14, P1040
[3]  
BEGG CB, 1983, CANCER, V52, P1986, DOI 10.1002/1097-0142(19831201)52:11<1986::AID-CNCR2820521103>3.0.CO
[4]  
2-7
[5]  
BERKOWITZ BA, 1975, CLIN PHARMACOL THER, V17, P629
[6]  
Bruera E, 1990, J Pain Symptom Manage, V5, P341, DOI 10.1016/0885-3924(90)90027-H
[7]   EFFECTS OF OXYGEN ON DYSPNEA IN HYPOXEMIC TERMINAL-CANCER PATIENTS [J].
BRUERA, E ;
DESTOUTZ, N ;
VELASCOLEIVA, A ;
SCHOELLER, T ;
HANSON, J .
LANCET, 1993, 342 (8862) :13-14
[8]  
CASSEL CK, 1996, CARING DYING IDENTIF
[9]   Survival of Medicare patients after enrollment in hospice programs [J].
Christakis, NA ;
Escarce, JJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (03) :172-178
[10]   ABSORPTION AND BIOAVAILABILITY OF NEBULIZED MORPHINE [J].
CHRUBASIK, J ;
WUST, H ;
FRIEDRICH, G ;
GELLER, E .
BRITISH JOURNAL OF ANAESTHESIA, 1988, 61 (02) :228-230